Loestrin 24 Fe Ad Campaign Targets Consumers Not Currently On Birth Control
This article was originally published in The Pink Sheet Daily
Executive Summary
Ads for Warner Chilcott’s 24-day oral contraceptive debuted May 15, directing consumers to studies demonstrating a shorter period duration.
You may also be interested in...
Berlex’ YAZ Clears FDA For Contraception; April Launch Planned
A premenstrual dysphoric disorder indication for the low-dose version of Yasmin is still pending.
Loestrin 24 Approved As First 24-Day Oral Contraceptive
Warner Chilcott beats out Berlex' Yaz as the first oral contraceptive approved in the U.S. with 24 active hormone days.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.